Teleophthalmology platform preventing vision impairment through remote screening
Ocumeda operates a teleophthalmology platform for remote eye screening, built on AWS, TypeScript, React, and Redshift. The company is actively scaling both its AI services for international rollout and the underlying infrastructure — evidenced by concurrent projects in data pipeline development, cost optimization, and quality assurance at scale. Sales hiring (8 roles) significantly outpaces engineering (3), indicating a shift from product-stage to market-expansion mode, with support and healthcare roles signaling operationalization of a regulated medical device.
Ocumeda is a Munich-based medical device company founded in 2019, focused on preventing blindness and vision impairment through teleophthalmology. The platform enables remote eye screenings and connects patients with ophthalmologists via telemedicine. The product stack includes an AI-driven screening component, a doctor onboarding program, and operational monitoring systems for post-release device management. The company is in active international expansion, with hiring across Germany, Peru, and Austria, and faces typical scaling challenges common to regulated AI-in-healthcare: cost control, quality consistency, daily operational reliability, and compliance with medical device regulations.
AWS infrastructure with TypeScript, Next.js, React, AWS CDK for frontend/deployment, Python for backend logic, SQL and Redshift for data warehousing, and Metabase for analytics dashboards.
Germany (headquarters in Munich), Peru, and Austria. Hiring velocity is currently accelerating.
Other companies in the same industry, closest in size